NASDAQ:MDVL MedAvail (MDVL) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MDVL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$1.80▼$5.9552-Week Range N/AVolume245,100 shsAverage Volume261,432 shsMarket Capitalization$2.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get MedAvail alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About MedAvail Stock (NASDAQ:MDVL)MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… MDVL Stock News HeadlinesApril 18, 2024 | morningstar.comDelhi Bank Corp DWNXFebruary 12, 2024 | msn.comUS Stocks Mixed; Trimble Issues Weak OutlookApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 12, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.33%February 9, 2024 | msn.comMedAvail Holdings Faces Nasdaq Delisting After BankruptcyFebruary 8, 2024 | msn.comWall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than ExpectedFebruary 8, 2024 | msn.comUS Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade DataFebruary 6, 2024 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.37%April 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 6, 2024 | msn.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.37%February 3, 2024 | msn.comMedAvail Holdings Files for Chapter 7 BankruptcyFebruary 2, 2024 | msn.comDow Falls 150 Points; US Economy Adds 353,000 Jobs In JanuaryJanuary 31, 2024 | investing.comMedavail Holdings Inc (MDVL)November 28, 2023 | finance.yahoo.comMedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCentersNovember 18, 2023 | morningstar.comMedAvail Holdings Inc Ordinary Shares MDVLNovember 18, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | msn.comMedAvail receives non-compliance notice from NasdaqNovember 17, 2023 | benzinga.comMedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | finance.yahoo.comMedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-QNovember 17, 2023 | finance.yahoo.comMedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCentersNovember 10, 2023 | msn.comMDVL, BACK and FTEL are among mid-day moversAugust 30, 2023 | finance.yahoo.comMedAvail to Participate in H.C. Wainwright 25th Annual Global Investment ConferenceAugust 16, 2023 | finance.yahoo.comPotential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without RiskAugust 15, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comMedAvail Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | finance.yahoo.comMedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCentersAugust 1, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Announces 1-for-50 Reverse Stock SplitSee More Headlines Receive MDVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolNASDAQ:MDVL CUSIPN/A CIK1402479 Webwww.medavail.com Phone(905) 812-0023Fax973-348-5707Employees279Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($28.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,620,000.00 Net Margins-192.97% Pretax MarginN/A Return on Equity-218.10% Return on Assets-103.45% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$43.33 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$13.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,614,000Free Float1,590,000Market Cap$2.91 million OptionableNo Data Beta0.76 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mark Doerr RPh (Age 54)CEO, President & Director Comp: $424.42kMs. Ramona Seabaugh (Age 55)CFO, Treasurer & Secretary Comp: $367.94kEmilia KericSenior VP & General CounselMs. Joan O'RourkePresident of SpotRxMr. Brian SchlerfCorporate ControllerKey CompetitorsNemaura MedicalNASDAQ:NMRD60 Degrees PharmaceuticalsNASDAQ:SXTPAvalon GloboCareNASDAQ:ALBTAraviveNASDAQ:ARAVProSomnusNASDAQ:OSAPView All CompetitorsInsidersRamona SeabaughSold 303 sharesTotal: $1,727.10 ($5.70/share)View All Insider Transactions MDVL Stock Analysis - Frequently Asked Questions How were MedAvail's earnings last quarter? MedAvail Holdings, Inc. (NASDAQ:MDVL) posted its quarterly earnings data on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.32) by $0.02. The company had revenue of $5.79 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%. During the same quarter in the previous year, the business posted ($0.84) EPS. This page (NASDAQ:MDVL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAvail Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
